Helping NET Cancer patients get a timely diagnosis,
the best care and ultimately a cure
If you don’t suspect it you can’t detect it
84% of NET patients
Their needs for information about treatment
options were not met at the time of diagnosis.
58% of NET patients are
diagnosed at an advanced stage
How Can I Help?
The Carcinoid Cancer Foundation hosted a special Facebook Live Event on January 23, featuring neuroendocrine tumor (NET) expert Dr. Jonathan Strosberg for an in-depth discussion about Peptide Receptor Radionuclide Therapy (PRRT). Participants were able to submit...read more
CNETS Canada was formed in 2007 to assist the Canadian community with this type of disease. Today, CNETS Canada is widely recognized by patients and the medical community across Canada, as an organization that helps improve the quality of life and survival for NET...read more
NETRF gave an Accelerator Award to Hans Clevers, MD, PhD, Hubrecht Institute, Netherlands, to develop NET organoids to expand the field’s preclinical NET research tools in 2017. An organoid is a laboratory replica of tumor cells that researchers can study to...read more